Background illustration for clinical trials search

Paid Clinical Trials Newark

Discover 1,568 paid clinical trials in Newark, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers

for
Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma,
Location: Hackensack NJ, Boston MA, Buffalo NY, Pittsburgh PA,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT06469281

Phase1, Recruiting

Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma

for
Relapsed Classic Hodgkin Lymphoma
Location: Hackensack NJ, Boston MA, Chicago IL, Nashville TN,
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT04561206

Phase2, Recruiting

Phase IB/II of CPX-351 for Relapse Prevention in AML

for
Acute Myeloid Leukemia (AML) in Remission
Location: Hackensack NJ, Philadelphia PA, Washington D.C. DC
Sponsor: Georgetown University

Sex: All

Age: 18+

Code: NCT04990102

Phase1, Phase2, Recruiting

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

for
Breast Cancer
Location: Hackensack NJ, New Brunswick NJ, Stony Brook NY,
Sponsor: Exact Sciences Corporation

Sex: All

Age: 18+

Code: NCT06401421

Recruiting

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

for
Lung Cancer, Breast Cancer
Location: Hackensack NJ, Montreal, Ottawa, Cleveland OH,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06618287

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Hackensack NJ, Broomall PA, Norwich CT, Albany NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136559

Phase3, Recruiting

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Englewood NJ, East Stroudsburg PA, Meadowbrook PA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 0+

Code: NCT04242095

Recruiting

A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC

for
Nonmuscle-invasive Bladder Cancer
Location: New Brunswick NJ, Pittsburgh PA, Middleburg Heights OH,
Sponsor: ImmVira Pharma Co. Ltd

Sex: All

Age: 18+

Code: NCT06971614

Phase2, Recruiting

A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors

for
Thymoma, Thymic Carcinoma
Location: Hackensack NJ, Washington D.C. DC, Chicago IL,
Sponsor: Georgetown University

Sex: All

Age: 18+

Code: NCT06248515

Phase2, Recruiting

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

for
Small Cell Lung Cancer
Location: Hackensack NJ, Boston MA, Buffalo NY, Chicago IL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06780137

Phase1, Phase2, Recruiting

A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)

for
Solid Tumors
Location: Hackensack NJ, New Haven CT, Los Angeles CA
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT05471856

Phase1, Recruiting

International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

for
Gaucher Disease, Cerebroside Lipidosis Syndrome,
Location: New York NY, Paterson NJ, Hackensack NJ, Morristown NJ,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00358943

Recruiting

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

for
Cervical Cancer,
Location: Hackensack NJ, Montreal, Hamilton, Nashville TN,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT04895709

Phase1, Phase2, Recruiting

Amnioband and Standard of Care vs. Standard of Care Alone in the Treatment of Venous Leg Ulcers

for
Venous Leg Ulcers
Location: Brick NJ, Boston MA, Ford City PA, Kittanning PA,
Sponsor: SerenaGroup, Inc.

Sex: All

Age: 18+

Code: NCT02609594

Recruiting
New

A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma

for
Multiple Myeloma
Location: Hackensack NJ, Washington D.C. DC
Sponsor: Hackensack Meridian Health

Sex: All

Age: 18+

Code: NCT04661137

Phase2, Recruiting

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

for
Low Risk Myelodysplastic Syndromes
Location: Hackensack NJ, New York NY, Cleveland OH, Durham NC,
Sponsor: Rigel Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05308264

Phase1, Phase2, Recruiting

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

for
Advanced Non-Small Cell Lung Cancer,
Location: Hackensack NJ, Teaneck NJ, The Bronx NY,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT04613596

Phase2, Phase3, Recruiting

Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol

for
Binge-Eating Disorder
Location: New York NY, Princeton NJ, Mount Kisco NY,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 18 - 55

Code: NCT06413433

Phase3, Recruiting

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: New York NY, New Brunswick NJ, New Haven CT, Newark DE,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06921785

Phase3, Recruiting

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

for
Smoldering Plasma Cell Myeloma
Location: New York NY, Morristown NJ, Greenwich CT, Stamford CT,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT03937635

Phase3, Recruiting